Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Links shared publicly online about this topic.

488
total visits

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease - including hypertrophic cardiomyopathy, a thickening of the heart muscle that is the leading cause of sudden death in children and young adults -, have introduced these mutations into mice and successfully treated HCM in the lab.

View full resource at news-medical.net

Tags: Heart, Heart Disease, Congenital Heart Defect, Stroke, Cancer, Thrombotic Event, News